Atypical PKC Phosphorylates Microtubule Affinity-regulating Kinase 4 in Vitro

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2015 Sep 9

PMID 26346160

Citations 7

Authors

Farha Naz

Asimul Islam

Faizan Ahmad

Md Imtaiyaz Hassan

Affiliations

Soon will be listed here.

Abstract

MAP/Microtubule affinity-regulating kinase 4 (MARK4), a Ser/Thr protein kinases, is related to the Par-1 (partitioning-defective) gene products, and is the human ortholog of Par-1. MARK4 shows its role in the cell polarity at the time of embryonic development. It is mostly located at the basal region of cells, providing apico-basal polarity. Here, we made two variants of human Par-1d (MARK4), kinase domain (MARK4-F2), and kinase domain along with 59 N-terminal residues (MARK4-F1) and saw their ATPase hydrolysis in the presence of each other. We observed that the activity of one variant was increased in the presence of other. We also demonstrated that both variants were phosphorylated by atypical PKC and their activities were increased in the presence of increasing concentration of atypical protein kinase c (aPKC). The phosphorylation was observed at the serine and threonine residues of MARK4. The interaction of MARK2 and MARK3 with aPKC and their negative regulation by aPKC is already known. This study confirms a functional link between aPKC and MARK4, two central determinants of cell polarity, and it suggests that aPKC may regulate all four members of Par-1 through phosphorylating them in polarized cells.

Citing Articles

Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer's disease? From preclinical studies to the clinical trials.

Basheer N, Smolek T, Hassan I, Liu F, Iqbal K, Zilka N Mol Psychiatry. 2023; 28(6):2197-2214.

PMID: 37264120 PMC: 10611587. DOI: 10.1038/s41380-023-02113-z.

A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma.

Ahmed S, Mobashir M, Al-Keridis L, Alshammari N, Adnan M, Abid M Front Oncol. 2022; 12:914032.

PMID: 35936719 PMC: 9355243. DOI: 10.3389/fonc.2022.914032.

Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration.

Oba T, Saito T, Asada A, Shimizu S, Iijima K, Ando K J Biol Chem. 2020; 295(50):17138-17147.

PMID: 33020179 PMC: 7863894. DOI: 10.1074/jbc.RA120.014420.

Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones.

Voura M, Khan P, Thysiadis S, Katsamakas S, Queen A, Hasan G Sci Rep. 2019; 9(1):1676.

PMID: 30737440 PMC: 6368574. DOI: 10.1038/s41598-018-38217-8.

Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies.

Khan P, Rahman S, Queen A, Manzoor S, Naz F, Hasan G Sci Rep. 2017; 7(1):9470.

PMID: 28842631 PMC: 5573368. DOI: 10.1038/s41598-017-09941-4.

References

Inglis J, Lee M, Hill R . Emk, a protein kinase with homologs in yeast maps to mouse chromosome 19. Mamm Genome. 1993; 4(7):401-3. DOI: 10.1007/BF00360595. View

Naz F, Singh P, Islam A, Ahmad F, Hassan M . Human microtubule affinity-regulating kinase 4 is stable at extremes of pH. J Biomol Struct Dyn. 2015; 34(6):1241-51. DOI: 10.1080/07391102.2015.1074942. View

Lizcano J, Goransson O, Toth R, Deak M, Morrice N, Boudeau J . LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004; 23(4):833-43. PMC: 381014. DOI: 10.1038/sj.emboj.7600110. View

Manning G, Whyte D, Martinez R, Hunter T, Sudarsanam S . The protein kinase complement of the human genome. Science. 2002; 298(5600):1912-34. DOI: 10.1126/science.1075762. View

Hurov J, Stappenbeck T, Zmasek C, White L, Ranganath S, Russell J . Immune system dysfunction and autoimmune disease in mice lacking Emk (Par-1) protein kinase. Mol Cell Biol. 2001; 21(9):3206-19. PMC: 86958. DOI: 10.1128/MCB.21.9.3206-3219.2001. View

Pace C, Vajdos F, Fee L, Grimsley G, Gray T . How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 1995; 4(11):2411-23. PMC: 2143013. DOI: 10.1002/pro.5560041120. View

Tassan J, Le Goff X . An overview of the KIN1/PAR-1/MARK kinase family. Biol Cell. 2004; 96(3):193-9. DOI: 10.1016/j.biolcel.2003.10.009. View

Timm T, Marx A, Panneerselvam S, Mandelkow E, Mandelkow E . Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein. BMC Neurosci. 2008; 9 Suppl 2:S9. PMC: 2604893. DOI: 10.1186/1471-2202-9-S2-S9. View

Peng C, Graves P, Ogg S, Thoma R, Byrnes 3rd M, Wu Z . C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ. 1998; 9(3):197-208. View

10.

Brajenovic M, Joberty G, Kuster B, Bouwmeester T, Drewes G . Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J Biol Chem. 2003; 279(13):12804-11. DOI: 10.1074/jbc.M312171200. View

11.

Naz F, Asad M, Malhotra P, Islam A, Ahmad F, Hassan M . Cloning, expression, purification and refolding of microtubule affinity-regulating kinase 4 expressed in Escherichia coli. Appl Biochem Biotechnol. 2014; 172(6):2838-48. DOI: 10.1007/s12010-014-0733-5. View

12.

Kato T, Satoh S, Okabe H, Kitahara O, Ono K, Kihara C . Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis. Neoplasia. 2001; 3(1):4-9. PMC: 1505019. DOI: 10.1038/sj.neo.7900132. View

13.

Naz F, Anjum F, Islam A, Ahmad F, Hassan M . Microtubule affinity-regulating kinase 4: structure, function, and regulation. Cell Biochem Biophys. 2013; 67(2):485-99. DOI: 10.1007/s12013-013-9550-7. View

14.

Hurov J, Watkins J, Piwnica-Worms H . Atypical PKC phosphorylates PAR-1 kinases to regulate localization and activity. Curr Biol. 2004; 14(8):736-41. DOI: 10.1016/j.cub.2004.04.007. View

15.

Timm T, Li X, Biernat J, Jiao J, Mandelkow E, Vandekerckhove J . MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J. 2003; 22(19):5090-101. PMC: 204455. DOI: 10.1093/emboj/cdg447. View

16.

Drewes G, Ebneth A, Preuss U, Mandelkow E, Mandelkow E . MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell. 1997; 89(2):297-308. DOI: 10.1016/s0092-8674(00)80208-1. View

17.

Spicer J, Rayter S, Young N, Elliott R, Ashworth A, Smith D . Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1. Oncogene. 2003; 22(30):4752-6. DOI: 10.1038/sj.onc.1206669. View

18.

Pellettieri J, Seydoux G . Anterior-posterior polarity in C. elegans and Drosophila--PARallels and differences. Science. 2002; 298(5600):1946-50. DOI: 10.1126/science.1072162. View

19.

Kemphues K . PARsing embryonic polarity. Cell. 2000; 101(4):345-8. DOI: 10.1016/s0092-8674(00)80844-2. View

20.

Espinosa L, Navarro E . Human serine/threonine protein kinase EMK1: genomic structure and cDNA cloning of isoforms produced by alternative splicing. Cytogenet Cell Genet. 1998; 81(3-4):278-82. DOI: 10.1159/000015046. View